Nu Skin Enterprises Balance Sheet Health
Financial Health criteria checks 6/6
Nu Skin Enterprises has a total shareholder equity of $754.0M and total debt of $238.8M, which brings its debt-to-equity ratio to 31.7%. Its total assets and total liabilities are $1.4B and $637.4M respectively. Nu Skin Enterprises's EBIT is $88.8M making its interest coverage ratio 4. It has cash and short-term investments of $216.3M.
Key information
31.67%
Debt to equity ratio
US$238.76m
Debt
| Interest coverage ratio | 4x |
| Cash | US$216.30m |
| Equity | US$753.97m |
| Total liabilities | US$637.44m |
| Total assets | US$1.39b |
Recent financial health updates
Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load
Feb 15
Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Recent updates
Nu Skin Enterprises (NYSE:NUS) Will Pay A Dividend Of $0.06
May 12Revenues Working Against Nu Skin Enterprises, Inc.'s (NYSE:NUS) Share Price Following 28% Dive
Apr 23Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Apr 17Should You Investigate Nu Skin Enterprises, Inc. (NYSE:NUS) At US$7.34?
Mar 25Improved Revenues Required Before Nu Skin Enterprises, Inc. (NYSE:NUS) Stock's 27% Jump Looks Justified
Mar 06Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be $0.06
Feb 17Here's Why Nu Skin Enterprises (NYSE:NUS) Is Weighed Down By Its Debt Load
Feb 15Nu Skin: New Cash From Mavely's Sale Could Accelerate Inorganic Growth
Jan 09Nu Skin Enterprises (NYSE:NUS) Will Be Looking To Turn Around Its Returns
Dec 21Does Nu Skin Enterprises (NYSE:NUS) Have A Healthy Balance Sheet?
Nov 12Nu Skin: New Products And Ongoing Digital Transformation Imply Undervaluation
Nov 12The Market Doesn't Like What It Sees From Nu Skin Enterprises, Inc.'s (NYSE:NUS) Revenues Yet As Shares Tumble 27%
Oct 04Nu Skin Enterprises' (NYSE:NUS) Returns On Capital Not Reflecting Well On The Business
Aug 31Insufficient Growth At Nu Skin Enterprises, Inc. (NYSE:NUS) Hampers Share Price
Aug 13Nu Skin Enterprises, Inc.'s (NYSE:NUS) CEO Might Not Expect Shareholders To Be So Generous This Year
May 30Is Nu Skin Enterprises (NYSE:NUS) Using Too Much Debt?
May 13Capital Allocation Trends At Nu Skin Enterprises (NYSE:NUS) Aren't Ideal
Mar 28Nu Skin: A Sell Signal Amidst Industry Decline And Strategic Uncertainty
Mar 04We Think You Can Look Beyond Nu Skin Enterprises' (NYSE:NUS) Lackluster Earnings
Feb 22Nu Skin Enterprises' (NYSE:NUS) Dividend Will Be Reduced To $0.06
Feb 19Analysts Just Shaved Their Nu Skin Enterprises, Inc. (NYSE:NUS) Forecasts Dramatically
Feb 18Nu Skin Enterprises, Inc. (NYSE:NUS) Could Be Riskier Than It Looks
Jan 18Nu Skin Enterprises (NYSE:NUS) Has A Somewhat Strained Balance Sheet
Dec 14Nu Skin Enterprises (NYSE:NUS) Has Affirmed Its Dividend Of $0.39
Nov 17Nu Skin: Is It Just A Growth Problem?
Oct 17Nu Skin Enterprises (NYSE:NUS) Could Be At Risk Of Shrinking As A Company
Oct 09When Should You Buy Nu Skin Enterprises, Inc. (NYSE:NUS)?
Sep 27Nu Skin: Attractive Valuation Trumps Near-Term Risks
Sep 12Nu Skin Enterprises (NYSE:NUS) Takes On Some Risk With Its Use Of Debt
Sep 08Nu Skin Enterprises (NYSE:NUS) Has Announced A Dividend Of $0.39
Aug 05Financial Position Analysis
Short Term Liabilities: NUS's short term assets ($524.9M) exceed its short term liabilities ($260.3M).
Long Term Liabilities: NUS's short term assets ($524.9M) exceed its long term liabilities ($377.1M).
Debt to Equity History and Analysis
Debt Level: NUS's net debt to equity ratio (3%) is considered satisfactory.
Reducing Debt: NUS's debt to equity ratio has reduced from 52.7% to 31.7% over the past 5 years.
Debt Coverage: NUS's debt is well covered by operating cash flow (45.6%).
Interest Coverage: NUS's interest payments on its debt are well covered by EBIT (4x coverage).
Balance Sheet
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/05/23 20:12 |
| End of Day Share Price | 2025/05/23 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Nu Skin Enterprises, Inc. is covered by 11 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Anand Vankawala | Avondale Partners |
| Olivia Tong Cheang | BofA Global Research |
| April Scee | BTIG |